scholarly journals Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome

2021 ◽  
Vol 2021 ◽  
pp. 1-3
Author(s):  
Hazlyna Baharuddin ◽  
Mohammad Hanafiah ◽  
Syazatul Syakirin Sirol Aflah ◽  
Mohd Arif Mohd Zim ◽  
Shereen Suyin Ch’Ng

Lymphocytic interstitial pneumonia (LIP) is a rare condition, commonly associated with Sjogren’s syndrome (SS). We report a 53-year-old woman with an incidental finding of an abnormal chest radiograph. LIP was diagnosed based on high-resolution computed tomography and lung biopsy, but treatment was not initiated. Six years later, she developed cough and dyspnoea, associated with dry eyes, dry mouth, and arthralgia. While being investigated for the respiratory symptoms, she developed cutaneous vasculitis and was treated with 1 mg/kg prednisolone, which resulted in the improvement of her respiratory symptoms. Physical examination revealed fine bibasal crepitations, active vasculitic skin lesions, and a positive Schirmer’s test. Investigations revealed a restrictive pattern in the pulmonary function test, stable LIP pattern in HRCT, and positive anti-Ro antibodies. She was treated with prednisolone and azathioprine for 18 months, and within this time, she was hospitalised for flare of LIP, as well as respiratory tract infection on three occasions. During the third flare, when she also developed cutaneous vasculitis, she agreed for prednisolone but refused other second-line agents. To date, she remained well with the maintenance of prednisolone 2.5 mg monotherapy for more than one year. The lessons from this case are (i) patients with LIP can be asymptomatic, (ii) LIP can precede symptoms of SS, and (iii) treatment decision for asymptomatic patients with abnormal imaging or patients with mild severity should be weighed between the risk of immunosuppression and risk of active disease.

Lung ◽  
2007 ◽  
Vol 185 (3) ◽  
pp. 187-188 ◽  
Author(s):  
Hirokazu Tokuyasu ◽  
Etsuko Watanabe ◽  
Ryota Okazaki ◽  
Yuji Kawasaki ◽  
Ryutaro Kikuchi ◽  
...  

2016 ◽  
Vol 33 (2) ◽  
pp. 112
Author(s):  
Eun Hye Lee ◽  
Ji Eun Park ◽  
Eun Kyong Goag ◽  
Young Joo Kim ◽  
In Young Jung ◽  
...  

2019 ◽  
Vol 52 (6) ◽  
pp. 410-411 ◽  
Author(s):  
Eurípedes Barsanulfo de Paula Avelino ◽  
Leonardo Verza ◽  
Tércia Neves ◽  
Rubens Chojniak ◽  
Marcos Duarte Guimarães

2019 ◽  
Vol 40 (02) ◽  
pp. 235-254 ◽  
Author(s):  
Augustine Chung ◽  
May Lin Wilgus ◽  
Gregory Fishbein ◽  
Joseph P. Lynch

AbstractSjogren's syndrome (SS) is a chronic autoimmune disease characterized by mononuclear cells (principally lymphocytes) infiltrating exocrine glands (e.g., salivary and lacrimal glands), leading to destruction of exocrine epithelial cells and dryness of mucosal surfaces. Cardinal symptoms are dry eyes (xerophthalmia) and dry mouth (xerostomia). Extraglandular sites are affected in 30 to 40% of cases of SS (particularly neurological, kidneys, skin, and lungs). B cell hyperactivity, autoantibody production, and hypergammaglobulinemia are cardinal features of SS. Primary SS is not associated with other autoimmune diseases. However, SS can complicate diverse autoimmune disorders (particularly systemic lupus erythematosus, rheumatoid arthritis, and scleroderma); this form is termed “secondary SS.” Pulmonary involvement is usually not a dominant feature of SS, but may be severe in some cases. In this review, we discuss specific tracheal, bronchiolar, and pulmonary complications of SS including xerotrachea, bronchiolitis, bronchiectasis, interstitial lung disease, nonspecific interstitial pneumonia, usual interstitial pneumonia, lymphoid interstitial pneumonia, organizing pneumonia, acute fibrinous and organizing pneumonia, pulmonary cysts, pleural effusions, pulmonary amyloidosis, and bronchus- or lung-associated lymphomas.


Sign in / Sign up

Export Citation Format

Share Document